Genetically engineered mice are critical experimental models for the study of breast cancer biology. Transgenic mice, employing strong mammary epithelial promoters to drive oncogenes, develop carcinomas with phenotypes corresponding to the molecular pathway activated. Gene-targeted (knockout) mice, in which tumor suppressors are deleted, develop mammary neoplasms with phenotypes primarily including patterns seen in spontaneous mouse mammary tumors, albeit at higher rates. Improved genetic engineering, using inducible gene expression, somatic gene transduction, conditional alleles, and crossbreeding for combined/compound genetic engineering yields precise molecular models with exquisite experimental control and phenotypes with comparative pathologic validity. Mammary gland transplantation technology adds a practical and validated method for assessing biologic behavior of selected mammary tissues. Overall, the many mouse models available are a rich resource for experimental biology with phenocopies of breast cancer subtypes, and a variety of practical advantages. The challenge is matching the model to the experimental question.T here is no perfect model system for studying breast cancer. Breast cancer in women constitutes an array of different diseases, and it is not realistic to consider breast cancer as a single disease. Experimental models are needed to reflect each part of the array. Cell culture lines are the most practical, and a panel of 51 standard cell lines is currently available reflecting most of the intrinsic subtypes of breast cancer (Neve et al. 2006). These cell lines are adapted to growth on two-dimensional (2D) plastic dishes and represent an oversimplified biology out of context. Growth in 3D culture is more contextual, but still simplified (Kenny et al. 2007). Even xenografting of human cell lines in mice is artificial, short-circuiting the precancer stage, the development of a permissive environment, and eliminating the immune system. Mouse models, particularly the genetically defined models offer a step in the direction of biologic reality. Choosing among the mouse models of breast cancer is not a trivial exercise. Literally thousands of specifically engineered mice have been created to study the pathology, molecular biology, natural history, and response to therapy in breast cancer (Borowsky 2007).